![]() companies’ products excel, is expected to enjoy continued growth throughout this time period. ![]() However, Japan’s patented drug market, a Japanese market segment in which U.S. One of the reasons for the projected decline in Japan’s pharmaceuticals market is a concurrent decline in Japan’s off-patent drug market. ![]() IQVIA, a leading global research organization, projects that Japan’s pharmaceuticals market will decrease at a rate of 0.2–1.2% per annum through 2025 while the global pharmaceuticals market is projected to grow at a rate of 4.4% over the same time period. pharmaceutical companies – including Pfizer, Eli Lilly, Merck, Biogen, Bristol Myers Squibb, Abbie, and Janssen – have subsidiaries in Japan. firms and compounds licensed to Japanese manufacturers, account for approximately 20% of Japan’s total pharmaceuticals imports.Īll major U.S. pharmaceutical imports into Japan, including local production by U.S. pharmaceutical imports’ share of Japan’s pharmaceuticals market is significantly higher than the percentage reflected in official statistics. The Japan Ministry of Health, Labour and Welfare’s (“MHLW’s”) Annual Pharmaceutical Production Statistics Report provides that the Japanese market for prescription and nonprescription pharmaceuticals in 2020 totaled USD $109 billion. Another important factor for increased interest in Japan’s pharmaceuticals sector is the need to enhance Japan’s drug discovery ecosystem. The COVID-19 pandemic, which demonstrated the importance of innovative healthcare products, is one reason for this heightened attention on Japan’s healthcare sector. Japan’s healthcare field, including the pharmaceuticals sector, has recently experienced renewed attention. Since 2013, the Government of Japan (“GOJ”) has promoted the healthcare industry as an important growth engine under the country’s economic revitalization and growth strategy. Japan is the third largest pharmaceutical market in the world and a critical export market for U.S. CS Japan estimated export and import data based on past trends. Commercial Service Japan (“CS Japan”) estimated 2021 local production and import data using MHLW monthly reports. Market size = local production + imports – exportsĭata Sources: Annual Pharmaceutical Production Statistics, Ministry of Health, Labour and Welfare (“MHLW”)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |